Authors

Jacob K. Kettle, PharmD, BCOP
Latest Article

Keeping Track of FGFR Inhibitor AEs Leads to Optimal Outcomes

This article explorex some of the more frequently encountered toxicities of FGFR inhibitors and their optimal management.

Daniel A. Vorobiof, MD

Daniel  is the Medical Director of Belong.Life, the world’s largest social network and navigator app for cancer patients, caregivers and medical professionals. He is the founder and former medical director of the Sandton Oncology Centre in Johannesburg and has published more than 100 peer reviewed articles in international medical journals. He formerly served as an executive board member of the International Committee of ASCO.

Latest Article

Caring for Patients With Cancer as COVID Rates Continue to Rise

Stringent and dedicated interventions are necessary to handle the spread of COVID-19, as this represents a major healthcare challenge for humanity, says Daniel Vorobiof, MD.

Herbert L. Duvivier, MD, JD
Latest Article

SCLC: Treatment Advancing 1 Small, but Quickening, Step at a Time

In 2019, there were approximately 30,000 new cases of small cell lung cancer diagnosed in the United States with nearly all cases attributable to cigarette smoking.

Lauren Bollinger, MD

Lauren Bollinger, MD is a gynecologic oncologist and surgeon seeing patients in Minneapolis, MN.

Latest Article

Cervical Cancer Awareness Month: Dramatic Increase in Cervical Cancer Research Is Driving Treatment Progress

For cervical cancer awareness month, Lauren Bollinger, MD, discusses how the increase in research in the field of cervical cancer is driving the progress of treatment.

Peter Baik, DO, FACOS, FACS
Peter Baik, DO, FACOS, FACS

Peter Baik, DO, FACOS, FACS, is a board-certified and fellowship-trained thoracic surgeon at Cancer Treatment Centers of America® (CTCA).

Latest Article

World Lung Cancer Day: Multiple Barriers Result in Low Lung Cancer Screening Rates

Although lung cancer screening rates are currently low, identifying the obstacles and potential solutions may raise the number of screenings in the United States.

Prasanth Reddy, MD, MPH
Latest Article

Incorporating Biomarker Testing in Community Cancer Clinics: A Real-World Pilot Study

Although there is tremendous excitement about boundaries of science stretching beyond human imagination, realizing the real-world impact of scientific advancement on the health outcomes of patients provides a reality check on how far we still must go.